TSX Venture Exchange, Satellos Bioscience Inc., View From The C-Suite
21 Agosto 2023 - 8:51PM
PR Newswire (Canada)
TORONTO, Aug. 21,
2023 /CNW/ - Frank Gleeson, Chief Executive
Officer, Satellos Bioscine (TSXV: MSCL) ("Satellos" or the
"Company") shares his Company's story in
an interview with TMX Group.
The View From The C-Suite video interview series highlights the
unique perspectives of listed companies on Toronto Stock Exchange
and TSX Venture Exchange. Videos provide insight into how
company executives think in the current business
environment. To see the latest View From The C-Suite visit
https://www.tmxmoney.com/en/csuite.html.
About Satellos Bioscience Inc.
(TSXV: MSCL)
Satellos is a biotechnology company dedicated to developing
lifechanging medicines to treat degenerative muscle conditions.
CNW sponsored announcement. To learn more visit
www.newswire.ca.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tsx-venture-exchange-satellos-bioscience-inc-view-from-the-c-suite-301905913.html
SOURCE TSX Venture Exchange
Copyright 2023 Canada NewsWire
Grafico Azioni Satellos Bioscience (TSXV:MSCL)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Satellos Bioscience (TSXV:MSCL)
Storico
Da Giu 2023 a Giu 2024